Revive Therapeutics, AMS partner to develop lyophilized formulation of Bucillamine
The collaboration between Revive and AMS aims to facilitate the transfer of technology for the lyophilized formulation of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Dec 23
The collaboration between Revive and AMS aims to facilitate the transfer of technology for the lyophilized formulation of…
22 Nov 23
With the completion of the second phase, Merck now offers a comprehensive range of biosafety testing services for…
22 Aug 23
Study Reveals Potential for New AI-Based Tools to Transform Enzyme Design, Catalyzing Cell-Free Bioproduction Across Multiple Industries
09 Aug 23
FDA-approved generic for MRI procedures is fully substitutable for Gadavist
04 Aug 23
Increased manufacturing capacity combined with an expansion from 69 to 92 eligible countries, is expected to enable delivery…
30 Jun 23
Posaconazole injection is indicated for prophylaxis of invasive Aspergillus and Candida infections in patients who are at high…
26 Jun 23
Under the partnership, both parties will start a therapeutic nutrition program that will use data from CGM technology…
26 Jun 23
After achieving primary endpoint by demonstrating superiority and non-inferiority in HbA1C reduction from baseline at week 52, investigative…
23 Jun 23
Now the iLet Bionic Pancreas is cleared for three insulins
03 Feb 23
Tezspire is a human monoclonal antibody that inhibits the action of TSLP, a key epithelial cytokine that plays…